Skip to main content

Table 2 Criteria for clinical diagnosis of the metabolic syndrome.

From: Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study

 

WHO

EGIR

NCEP

ACE

IDF

Prerequisite

DM, IFG, IGT, IR

insulin in top 25%

None

high risk*

WC ≥ 94 cm (men), WC ≥ 80 cm (women)†

No of criteria

and ≥ 2 of

and ≥ 2 of

≥ 3 of

and ≥ 2 of

and ≥ 2 of

Obesity

BMI > 30 and/or WHR > 0.9 (men), WHR > 0.85 (women)

WC ≥ 94 cm (men), WC ≥ 80 cm (women)

WC ≥ 102 cm (men), WC ≥ 88 cm (women)

  

BP (mmHg)

≥ 140/90

≥ 140/90‡

≥ 130/85‡

>130/85

≥ 130/85‡

HDL-C (mmol/l)

<0.9 (men), <1.0 (women)§ or

<1.0ठor

<1.0 (men), <1.3 (women)‡

<1.0 (men), <1.3 (women)

<1.0 (men), <1.3 (women)‡

TG (mmol/l)

≥ 1.7

>2.0‡

≥ 1.7‡

>1.7

>1.7‡

Glucose (mmol/l)

≥ 6.1, IGT

≥ 6.1 ||

≥ 5.6‡

≥ 6.1, IGT ||

≥ 5.6‡

  1. Please see list of abbreviations used. *high risk: diagnosis of CVD, hypertension, polycystic ovary syndrome, nonalcoholic fatty liver disease, or acanthosis nigricans; family history of type 2 diabetes, hypertension, or CVD; history of gestational diabetes or glucose intolerance; Non-Caucasian ethnicity, sedentary lifestyle, BMI > 25 kg/m2 or WC > 94 cm (men), >80 cm (women); and age >40 years [11]. †cut-off values differ according to ethnic origin [12]. ‡or treated for this abnormality. §lipid criterion consists of elevated triglycerides and/or low HDL in WHO and EGIR definitions and is counted as one component. || excludes patients with diabetes.